Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,310
Closed -$104K 84
2019
Q1
$104K Sell
1,310
-105
-7% -$7.85K 2.14% 11
2018
Q4
$104K Buy
+1,415
New +$99.9K 0.05% 143
2018
Q3
Sell
-11,895
Closed -$689K 161
2018
Q2
$689K Buy
+11,895
New +$671K 0.17% 110
2017
Q4
Sell
-5,450
Closed -$333K 168
2017
Q3
$333K Hold
5,450
0.1% 133
2017
Q2
$333K Hold
5,450
0.1% 134
2017
Q1
$330K Hold
5,450
0.1% 136
2016
Q4
$306K Buy
+5,450
New +$319K 0.1% 131
2014
Q2
Sell
-51,352
Closed -$2.78M 189
2014
Q1
$2.78M Buy
51,352
+38,776
+308% +$2.01M 0.93% 32
2013
Q4
$601K Sell
12,576
-5,764
-31% -$263K 0.19% 109
2013
Q3
$833K Sell
18,340
-8,384
-31% -$383K 0.28% 89
2013
Q2
$1.18M Buy
+26,724
New +$1.19M 0.43% 68

Other funds holding MRK

Loeb Partners Corp's MRK Position: Q2 2019 in Review

Loeb Partners Corp sold out of Merck (MRK) in Q2 2019, closing a stake of 1,310 shares — an estimated $104K sold.

Loeb Partners Corp first reported a position in MRK in Q2 2013 and held it in 11 quarters. The position peaked at $2.78M in Q1 2014. 2,299 funds tracked by Wall St. Rank hold MRK as of Q2 2019.

  • Loeb Partners Corp reported no remaining Merck position as of Q2 2019 after selling out during the quarter.
  • Loeb Partners Corp sold 1,310 Merck shares in Q2 2019, an estimated $104K.
  • Loeb Partners Corp first reported a position in Merck in Q2 2013 and held it in 11 quarters.
  • Loeb Partners Corp's Merck position peaked at $2.78M in Q1 2014.
  • 2,299 funds tracked by Wall St. Rank held Merck as of Q2 2019.

Based on Loeb Partners Corp's 13F filing for Q2 2019.